1. |
The FIELD study investigators. Effect of long term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet, 2005, 366(9500): 1849.
|
2. |
Bastow MD, Durrington PN, Ishola M. Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial. Metabolism, 1988, 37(3): 217-220.
|
3. |
Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol, 2008, 19(12): 2251-2253.
|
4. |
Liamis G, Bairaktari ET, Eliasf M. Effect of fenofibrate on serum uric acid levels. Am J Kidney Dis, 1999, 34: 594.
|
5. |
YamamokT, MoriwakiY, Takahashi S, et al. Effect offenofibrate on plasma concentration and urinary excretion of purine bases and oxyPurinol. Eur J ClinInvest, 2000, 30(10): 871-878.
|
6. |
王慧华, 李开沪, 朱秀英. 微粒化非诺贝特与苯扎贝特治疗老年高脂血症和高尿酸血症的比较. 老年医学与保健, 1999, 5(2): 73-75.
|
7. |
Elisaf M, Tsimichodimos V, Bairaktari E, et al. Effect of Micronized Fenofibrate and Losartan Combination on Uric Acid Metabolism in Hypertensive Patients with Hyperuricemia. Journal of Cardiovascular Pharmacology, 1999, 34(1): 60-63.
|
8. |
张文姚, 任爱华, 蒋益忠. 自身交叉试验比较非诺贝特与辛伐他汀降脂疗效及对ApoA、ApoB的影响. 心血管康复医学杂志, 2000, 9(2): 35-37.
|
9. |
王守俊, 刘瑞芳, 魏巧兰. 非诺贝特对糖尿病肾病的前瞻性研究. 辽宁实用糖尿病杂志, 2001, 9(3): 27-28.
|
10. |
Giral P, Bruckert E, Jacob N, et al. Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenobrate in patients with mixed hyperlipidemia. Atherosclerosis, 2001, 154(2): 421-427.
|
11. |
Insua A, Massari F, Moncalvo JJR, et al. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study. Endocr Pract, 2002, 8(2): 96-101.
|
12. |
秦利, 殷峻, 邢惠莉. 非诺贝特缓释微丸对糖尿病患者糖脂代谢紊乱的影响. 上海第二医科大学学报, 2003, 23(3): 261-263.
|
13. |
Milionis HJ, Papakostas J, Kakafika A, et al. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol, 2003, 43(8): 825-830.
|
14. |
孙学春. 微粒化非诺贝特对老年人血脂代谢紊乱的疗效观察. 四川医学, 2005, 26(9): 975-976.
|
15. |
Filippatos TD, Kiortsis DN, Liberopoulos EN, et al. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. Curr Med Res Opin, 2005, 21(12): 1997-2006.
|
16. |
刘玉庆, 史淑琴, 赵勇. 逐酸活血汤治疗原发性高尿酸血症并高三酰甘油血症30例的疗效观察. 中国实用医药, 2008, 3(34): 60-62.
|
17. |
Ansquer JC, Dalton RN, Caussé E, et al. Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people. Am J Kidney Dis, 2008, 51(6): 904-913.
|
18. |
王一扬, 王亦凡, 高振英. 非诺贝特治疗高甘油三酯症和高尿酸症的疗效. 药学与临床, 2009, 12(12): 1787-1789.
|
19. |
刘茜. 非诺贝特和普伐他汀调节血脂及尿酸的研究. 中华全科医学, 2010, 8(1): 60-62.
|
20. |
王大鹏, 高燕燕. 非诺贝特和苯溴马隆治疗高尿酸血症的效果. 齐鲁医学杂志, 2010, 25(6): 524-527.
|
21. |
Goto M. A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis. Mod Rheumatol, 2010, 20(3): 238-243.
|
22. |
Filippatos TD, Kiortsis DN, Liberopoulos EN, et al. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. Curr Med Res Opin, 2005, 21(12): 1997-2006.
|
23. |
Milionis HJ, Elisaf MS. Management of hypertension and dyslipidaemia in patients presenting with hyperuricaemia: case histories. Curr Med Res Opin, 2000, 16(3): 164-170.
|
24. |
Daskalopoulou SS, Tzovaras V, Mikhailidis DP, et al. Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Des, 2005, 11(32): 4161-4175.
|
25. |
Lipscombe J, Bargman JM. Fibrate-induced increase in blood urea and creatinine. Nephrol Dial Transplant, 2001, 16(7): 1515.
|
26. |
Davis TME, Ting R, Best JD, et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia, 2011, 54(2): 280–290.
|
27. |
Katsiki N, Papanas N, Fonseca VA, et al. Uric acid and diabetes: is there a link? Curr Pharm Des, 2013, 19(27): 4930-4937.
|